Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III randomized double-blind placebo-controlled study of isosorbide oral solution for Meniere's disease
CTR20243875Phase 3Terminated
- Sponsor
- Lunan Better Pharmaceutical Co., Ltd.
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Isosorbide oral solution (Lunan Better Pharmaceutical) in Meniere Disease, sponsored by Lunan Better Pharmaceutical Co., Ltd.. Started Nov 2024; status: terminated.
02
Drugs
Isosorbide oral solution (Lunan Better Pharmaceutical)
03
Conditions
Meniere Disease
Beyond the preview
Go deeper on CTR20243875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243875.